Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Devices

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Revenue projections:

Revenue projections for ZBH
Revenue projections for ZBH

ZBH's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.

Financial Ratios:

currentRatio 1.733000
forwardPE 9.218076
debtToEquity 58.912000
earningsGrowth 0.341000
revenueGrowth 0.093000
grossMargins 0.701180
operatingMargins 0.195720
trailingEps 3.860000
forwardEps 8.993200

ZBH's current ratio of 1.733, indicating that the company can meet its short-term debt obligations with ease. This high liquidity level is a positive sign, as ZBH has enough cash and current assets to handle its immediate liabilities comfortably.
With a forward EPS greater than its trailing EPS, ZBH is forecasted to be more profitable this year than last. This growth expectation reflects confidence in the company's earnings potential and suggests an improving financial trajectory for the year ahead.

Price projections:

Price projections for ZBH
Price projections for ZBH

ZBH's price projections have been steadily revised down, pointing to declining confidence in the company's outlook. This suggests that analysts are becoming more conservative in their expectations for ZBH's future performance.

Insider Transactions:

Insider Transactions for ZBH
Insider Transactions for ZBH


There were 8 ZBH stock sales, with market price at 98.66490459442139.During the period under consideration, there were no sell transactions.The recent trend of increased buying at Zimmer Biomet Holdings, Inc.'s current price levels may indicate a favorable market sentiment. This could point to a positive outlook for the stock, as investors show growing confidence through higher buy activity.

Recommendation changes over time:

Recommendations trend for ZBH
Recommendations trend for ZBH


The recent buy bias from analysts suggests Zimmer Biomet Holdings, Inc. is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, Zimmer Biomet Holdings, Inc. appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.